The Use of Exparel for Extended Pain Control in Minimally Invasive Cardiac Surgery
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2019
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 22 Jun 2016 Status changed from recruiting to discontinued.
- 24 Sep 2015 Planned End Date changed from 1 Nov 2015 to 1 Aug 2017 according to the ClinicalTrials.gov record.
- 24 Sep 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Aug 2016 according to the ClinicalTrials.gov record.